Skip to main content

Advertisement

Table 2 Predictors of CAM use

From: Complementary and alternative medicine use amongst Malaysian orthopaedic oncology patients

Variable All patients (N = 274) (%) Users of CAM N (%) Nonusers of CAM N (%) P OR 95% C1
Paediatric Yes 32 (11.7) 25 (78.1) 7 (21.9) 0.04 2.47 1.03–5.94
No 242 (88.3) 143 (59.1) 99 (40.9)    
Age range <20 58 (21.2) 38 (65.5) 20 (34.5) 0.43   
21–40 77 (28.1) 43 (55.8) 34 (44.2)    
41–60 78 (28.5) 52 (66.7) 26 (33.8)    
>60 61 (22.3) 35 (57.4) 26 (42.6)    
Gender Male 129 (47.1) 73 (56.6) 56 (43.4) 0.13 1.46 0.89–2.38
Female 145 (52.9) 95 (65.5) 50 (34.5)    
Race Malay 118 (43.1) 76 (64.4) 42 (35.6) 0.64   
Chinese 109 (39.8) 65 (59.6) 44 (40.4)    
Indians 47 (17.2) 27 (57.4) 20 (42.6)    
Marital status* Married 163 (67.4) 101 (62.0) 62 (38.0) 0.19 1.44 0.83–2.47
Not married 79 (32.6) 42 (53.2) 37 (46.8)    
Education* Primary/secondary 167 (69.0) 94 (56.3) 73 (43.7) 0.19 1.46 0.83–2.58
College/university 75 (31.0) 49 (65.3) 26 (34.7)    
Job status* Employed 109 (45.0) 61 (56.0) 48 (44.0) 0.37 1.27 0.76–2.12
Unemployed 133 (55.0) 82 (61.7) 51 (38.3)    
Income* Less than 1000 151 (62.4) 91 (60.3) 60 (39.7) 0.63 1.14 0.67–1.93
More than 1000 91 (37.6) 52 (57.1) 39 (42.9)    
Presence of metastasis Yes 88 (32.1) 62 (70.5) 26 (29.5) 0.03 1.80 1.05–3.10
No 186 (67.9) 106 (57.0) 80 (43.0)    
Malignancy Malignant 181 (66.1) 123 (68.0) 58 (32.0) 0.002 2.26 1.36–3.78
Benign 93 (33.9) 45 (48.4) 48 (51.6)    
Chemotherapy Yes 73 (26.6) 55 (75.3) 18 (24.7) 0.004 2.38 1.31–4.34
No 201 (73.4) 113 (56.2) 88 (43.8)    
Surgery Yes 206 (75.2) 137 (66.5) 69 (33.5) 0.002 2.37 1.36–4.14
No 68 (24.8) 31 (45.6) 37 (54.4)    
Radiotheraphy Yes 51 (18.6) 35 (68.6) 16 (31.4) 0.24 1.48 0.77–2.83
  No 233 (81.4) 133 (59.6) 90 (40.4)    
  1. N = 274 for all variables, except variables labelled * (N = 242) as variable* excludes paediatric patients.